Dr. Silke Roedder has been working in human biomarker research for 8 years, with a strong focus on the development of non-invasive molecular markers for the diagnosis and prediction, as well as for individual patient monitoring, and repositioning of FDA approved drugs in the field of Solid Organ Transplantation and Immunology.

As Pharmacist with a Ph.D. in Biomedical Sciences, Dr. Roedder is highly skilled in translational research, including hands-on in-silico (QPCR, Microarray, ELISA, Western Blot, Zymography, Laser Capture Microdissection), in-vitro (cell-culture, cell assays), and in-vivo (animal models of organ rejection) Experiments, the Analysis of high- and low-throughput genomic and proteomic Data including the development of statistical algorithm for classification, in writing of Grants, Original- and Review Articles for Publication. In addition to Study and experimental design, Management of Personnel, interdisciplinary, international and national collaborations, written and oral communication at national and international meetings and seminars.

Dr. Roedder has published 13 original articles in PubMed, including 2 invited Reviews, 25 Abstracts at international and national Meetings, and is Co-Author of a Patent Application for non-invasive markers in Preeclampsia. Dr. Roedder also regularly reviews articles for AJT and PlosOne and she is an active meeting of 5 professional Organizations.